Perrigo Recalls Clindamycin and Benzoyl Peroxide Gel Due to Mold
L. Perrigo Company is recalling 162,534 tubes of Clindamycin Phosphate and Benzoyl Peroxide Gel because a small number of tubes may contain mold on the cap.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation that could cause temporary or medically reversible adverse health consequences. The hazard is limited to mold on the cap of a non-sterile product, with no reported illnesses or injuries.
Plain-English summary
L. Perrigo Company is voluntarily recalling 162,534 tubes of Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%, 45 g. The product is a prescription-only topical gel manufactured in Israel and distributed nationwide in the United States.
The recall was initiated due to microbial contamination of the non-sterile product. Specifically, a small number of tubes may include the presence of mold on the cap. The affected product is identified by NDC 45802-736-84 and UPC 345802736840. Specific lot codes and expiration dates are listed in the official recall notice.
Consumers and healthcare providers should stop using the recalled product and return it to the pharmacy or point of purchase for a refund or replacement. Patients should consult their healthcare provider for alternative treatment options if necessary.
The recalled product
- Product
- CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (CLINDAMYCIN, BENZOYL PEROXIDE)
- Brand
- CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
- Manufacturer
- L. Perrigo Company
- Category
- Drug — Topical Prescription
- Affected units
- 162,534
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
UPCs (1)
- 345802736840
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · L. Perrigo Company
See all →- HighBASIC CARE Allergy Tablets Recalled Due to Failed Quality Specifications
FDA (Drugs) · 2023-07-19
- HighFexofenadine Hydrochloride Tablets Recalled for Failed Purity Specifications
FDA (Drugs) · 2023-07-19
- HighAllergy Relief Fexofenadine Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Allergy Relief Tablets Recalled for Failed Manufacturing Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Antihistamine Tablets Recalled for Failed Quality Specifications
FDA (Drugs) · 2023-07-19
Same hazard · microbial contamination
See all →- CriticalVictory Medical Center Pharmacy Recalls Glutathione Vials Due to Contamination
FDA (Drugs) · 2026-08-19
- HighMedline Medical Convenience Kits Recalled Due to Potential Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighMedline Convenience Kits Recalled Over Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15